$MLSS News

Last published 1h ago

1h agoMLSSCORRECTION: Milestone Scientific Schedules Third Quarter 2026 Financial Results Conference CallGlobeNewswireIn a release issued under the same headline earlier today by Milestone Scientific, Inc., please note that in the first paragraph of the release, the conference call date should have been Friday, November 13, not Wednesday, November 13, as previously stated .
2h agoMLSSMilestone Scientific Schedules Third Quarter 2026 Financial Results Conference CallGlobeNewswireROSELAND, N.J., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments...
1w agoMLSSMilestone Scientific Provides Major Commercial Growth Update as CompuFlo® Expands Across 30 Million+ Annual Global Epidural ProceduresGlobeNewswireCompany Reports 500+ U.S. Leads, Expanding Healthcare Network Relationships, Federal Market Access, International Distribution and 300+ Issued and Pending Patents Worldwide Just 2% Penetration of Estimated U.S.
1mo agoMLSSMilestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and AdvisorGlobeNewswireROSELAND, N.J., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery and injection technologies, today announced that Sudhir Rao, M.D., Medical
2mo agoMLSSMilestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three DirectorsGlobeNewswireROSELAND, N.J., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that
2mo agoMLSSMilestone Scientific Reports Financial Results for Second Quarter 2026GlobeNewswireMedical Segment Revenue Grows 231% Year-Over-Year Enters Strategic Distribution Agreement to Expand CompuFlo® Access Across VA and Department of Defense Health Systems Reaffirms 2026 Outlook for Double-Digit Revenue
3mo agoMLSSMilestone Scientific Schedules Second Quarter 2026 Financial Results Conference CallGlobeNewswireROSELAND, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that
3mo agoMLSSMilestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural SystemGlobeNewswireROSELAND, N.J., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a medical technology company specializing in advanced injection and drug-delivery technologies, today announced that it has
3mo agoMLSSMilestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026GlobeNewswireAI-powered Initiative Aims to Enhance Customer Engagement, Accelerate Commercial Execution and Support Long-Term Growth Visit booth #112 in the Sparkle Ballroom at Fontainebleau Miami Beach for a live demonstration of
4mo agoMLSSMilestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoYGlobeNewswireMedical Segment Momentum Accelerates, Posting 300% Growth Versus Q2 2025 Company to Showcase Technology at American Society of Pain & Neuroscience Conference in Miami Beach, July 16–18, Alongside Board Member and
4mo agoMLSSMilestone Scientific Strengthens Board to Support Next Phase of GrowthGlobeNewswireROSELAND, N.J., June 25, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced a
5mo agoMLSSMilestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain ProceduresGlobeNewswireROSELAND, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments utilizing Dynamic Pressure Sensing™ (DPS) technology, today
6mo agoMLSSMilestone Scientific Reports Financial Results for First Quarter 2026GlobeNewswireOperating Loss Reduced As Company Advances Toward Profitability Reaffirms Outlook for Double-Digit Revenue Growth in 2026, including Significant Growth in CompuFlo® Sales ROSELAND, N.J., May 14, 2026 (GLOBE
6mo agoMLSSMilestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference CallGlobeNewswireROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced
6mo agoMLSSMilestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical AdoptionGlobeNewswireROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, today provided an update on the expansion of its CompuFlo®
6mo agoMLSSMilestone Scientific Inc. Completes $2.15 Million Private PlacementGlobeNewswireROSELAND, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the
7mo agoMLSSMilestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025GlobeNewswireQ4 2025 Marks Transition from Restructuring to Growth For 2026, Expects Double-Digit Revenue Growth, 400% Increase in CompuFlo Sales, and Continued Progress Toward Profitability ROSELAND, N.J., March 31, 2026
7mo agoMLSSMilestone Scientific Schedules Fourth Quarter and FY 2025 Financial Results and Business Update Conference CallGlobeNewswireROSELAND, N.J., March 26, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced
8mo agoMLSSMilestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National ExpansionGlobeNewswireROSELAND, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced
10mo agoMLSSMilestone Scientific Launches The Wand® Ambassador Program to Expand Peer Engagement and Accelerate Market Adoption in DentistryGlobeNewswireROSELAND, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the
12mo agoMLSSMilestone Scientific Delivers Stable Revenue and Reduces Operating Expenses by Over $500 Thousand in the Third Quarter of 2025GlobeNewswireROSELAND, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced
12mo agoMLSSMilestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference CallGlobeNewswireROSELAND, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that
1y agoMLSSMilestone Scientific Highlights Operational Progress and Growth Initiatives Under New LeadershipGlobeNewswireROSELAND, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a
1y agoMLSSMilestone Scientific Commits to Regaining NYSE American Compliance Following NotificationGlobeNewswireROSELAND, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that
1y agoMLSSMilestone Scientific Appoints Dr. Dawood Sayed to Board of Directors to Advance Commercial and Clinical Strategy in Pain ManagementGlobeNewswireROSELAND, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the
1y agoMLSSMilestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025GlobeNewswireROSELAND, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provides a
1y agoMLSSMilestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference CallGlobeNewswireROSELAND, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that
1y agoMLSSMilestone Scientific Appoints Jason Papes as Senior Vice President, Global Head of Sales and MarketingGlobeNewswireROSELAND. N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the
1y agoMLSSMilestone Scientific Appoints Eric C. Hines as Chief Executive OfficerGlobeNewswireROSELAND, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the
1y agoMLSSMilestone Scientific Commences Sales of CompuFlo® Epidural System at The Painless Center in Tenafly, New JerseyGlobeNewswireROSELAND, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the
1y agoMLSSMilestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of DirectorsGlobeNewswireROSELAND, N.J., May 19, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that
1y agoMLSSMilestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025GlobeNewswireROSELAND, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a
1y agoMLSSMilestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025GlobeNewswireReports expansion of CompuFlo® Epidural System across additional pain management clinics and ambulatory surgery centers following Medicare price assignment in multiple U.S. states ROSELAND, N.J., April 15, 2025
1y agoMLSSMilestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New JerseyGlobeNewswireROSELAND, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that
1y agoMLSSMilestone Scientific Expands Adoption of CompuFlo® Epidural System with Commercial Rollout at Pain Doctors Medical LLCGlobeNewswireROSELAND, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the
1y agoMLSSMilestone Scientific to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference on December 11th, 2024GlobeNewswireROSELAND, N.J., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that
1y agoMLSSMilestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFlo® Epidural SystemGlobeNewswireROSELAND, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced its
1y agoMLSSMilestone Scientific Inc. (MLSS) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
1y agoMLSSMilestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024GlobeNewswireReports 57% increase in international dental sales for the third quarter of 2024 Advances commercial rollout of CompuFlo® Epidural System across additional pain management clinics following Medicare price
1y agoCTHR MLSSMilestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEOGlobeNewswireROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that
1y agoMLSSMilestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference CallGlobeNewswireROSELAND, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that
2y agoMLSSMilestone Scientific Expands Commercial Rollout of the CompuFlo® Epidural System with Esteemed Pain Management Physician Dr. Elbaz at Hudson Specialty CareGlobeNewswireRecent Medicare Price Assignment Driving Increased Access to CompuFlo Milestone Scientific to Attend New York and New Jersey Pain Medicine Congress 2024 ROSELAND, N.J., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Milestone
2y agoMLSSMilestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at iHeal Pain Center Following Medicare Price AssignmentGlobeNewswireROSELAND, N.J., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that
2y agoMLSSMilestone Scientific Inc. (MLSS) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoMLSSMilestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2024GlobeNewswireSecured Medicare price assignment for the CompuFlo® Epidural System in multiple U.S. states Gross margin for the second quarter of 2024 increased to 76.1% from 65.0% for the same period last year driven by an
2y agoMLSSMilestone Scientific Schedules Second Quarter 2024 Financial Results and Business Update Conference CallGlobeNewswireROSELAND, N.J., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that
2y agoMLSSMilestone Scientific Announces Strategic Partnership with Axial Biologics to Distribute CompuFlo® in New Jersey, Texas, and FloridaGlobeNewswireROSELAND, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced a
2y agoMLSSMilestone Scientific Secures Key Patent Approvals in the U.S. and EuropeGlobeNewswireROSELAND, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced
2y agoMLSSMilestone Scientific Announces Medicare Price Assignment for the CompuFlo® Epidural System in Texas, Pennsylvania, New Jersey, Maryland, Colorado, Oklahoma, Louisiana, Arkansas, Mississippi, New Mexico, District of Columbia, and DelawareGlobeNewswireROSELAND, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that
2y agoMLSSMilestone Scientific Announces Favorable Medicare Pricing for its CompuFlo® Epidural System within First JMAC Region Covering FloridaGlobeNewswireROSELAND, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced at